Epidemiology of cancer of the small intestine.

Sai Yi Pan, Howard Morrison
Author Information
  1. Sai Yi Pan: Sai Yi Pan, Howard Morrison, Science Integration Division, Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, Ottawa, Ontario, K1A 0K9, Canada.

Abstract

Cancer of the small intestine is very uncommon. There are 4 main histological subtypes: adenocarcinomas, carcinoid tumors, lymphoma and sarcoma. The incidence of small intestine cancer has increased over the past several decades with a four-fold increase for carcinoid tumors, less dramatic rises for adenocarcinoma and lymphoma and stable sarcoma rates. Very little is known about its etiology. An increased risk has been noted for individuals with Crohn's disease, celiac disease, adenoma, familial adenomatous polyposis and Peutz-Jeghers syndrome. Several behavioral risk factors including consumption of red or smoked meat, saturated fat, obesity and smoking have been suggested. The prognosis for carcinomas of the small intestine cancer is poor (5 years relative survival < 30%), better for lymphomas and sarcomas, and best for carcinoid tumors. There has been no significant change in long-term survival rates for any of the 4 histological subtypes. Currently, with the possible exceptions of obesity and cigarette smoking, there are no established modifiable risk factors which might provide the foundation for a prevention program aimed at reducing the incidence and mortality of cancers of the small intestine. More research with better quality and sufficient statistical power is needed to get better understanding of the etiology and biology of this cancer. In addition, more studies should be done to assess not only exposures of interest, but also host susceptibility.

Keywords

References

  1. Ann Intern Med. 1998 Jun 1;128(11):896-9 [PMID: 9634427]
  2. Am J Gastroenterol. 2005 Mar;100(3):703-10 [PMID: 15743371]
  3. Gut. 2004 May;53(5):774 [PMID: 15082608]
  4. World J Surg. 2006 Mar;30(3):391-8; discussion 399 [PMID: 16479330]
  5. Int J Colorectal Dis. 2001 Apr;16(2):63-75 [PMID: 11355321]
  6. J Gastroenterol Hepatol. 2010 Feb;25(2):319-24 [PMID: 19929927]
  7. QJM. 2003 May;96(5):345-53 [PMID: 12702783]
  8. Cancer Causes Control. 2006 Sep;17(7):901-9 [PMID: 16841257]
  9. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1545-9 [PMID: 16896047]
  10. J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):170-6 [PMID: 19516192]
  11. Cancer. 1998 Jul 15;83(2):240-4 [PMID: 9669805]
  12. Cancer Lett. 2004 May 28;208(2):155-61 [PMID: 15142673]
  13. Eur J Cancer. 1996 Nov;32A(12):2114-9 [PMID: 9014754]
  14. Dis Colon Rectum. 2004 May;47(5):778-81 [PMID: 15037927]
  15. Cancer. 2000 Jan 15;88(2):286-94 [PMID: 10640959]
  16. Am J Clin Nutr. 1999 Mar;69(3):354-65 [PMID: 10075317]
  17. Cancer. 1983 Oct 15;52(8):1410-6 [PMID: 6193858]
  18. Int J Cancer. 2006 Jan 1;118(1):189-96 [PMID: 16003748]
  19. Gastroenterology. 2001 Nov;121(5):1127-35 [PMID: 11677205]
  20. Arch Intern Med. 2003 Jul 14;163(13):1566-72 [PMID: 12860579]
  21. J Med Genet. 2003 Mar;40(3):208-13 [PMID: 12624141]
  22. Gut. 2006 Jul;55(7):984-90 [PMID: 16407375]
  23. Am J Surg. 1997 Mar;173(3):237-9 [PMID: 9124635]
  24. Cancer Causes Control. 2005 Sep;16(7):781-7 [PMID: 16132788]
  25. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):205-7 [PMID: 8019367]
  26. Arch Intern Med. 2003 Feb 10;163(3):286-92 [PMID: 12578508]
  27. Gastroenterology. 2009 Jul;137(1):88-93 [PMID: 19362553]
  28. Am J Gastroenterol. 1999 Apr;94(4):1047-52 [PMID: 10201481]
  29. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49 [PMID: 19474385]
  30. Curr Opin Gastroenterol. 2010 Mar;26(2):116-22 [PMID: 20040864]
  31. J Clin Gastroenterol. 2001 Oct;33(4):267-82 [PMID: 11588539]
  32. Dig Dis Sci. 1989 Feb;34(2):167-70 [PMID: 2536604]
  33. Br J Cancer. 2005 Jul 11;93(1):159-66 [PMID: 15970927]
  34. Ann Epidemiol. 2009 Jan;19(1):58-69 [PMID: 19064190]
  35. Am J Gastroenterol. 2001 Jan;96(1):126-31 [PMID: 11197241]
  36. Nature. 2007 Aug 16;448(7155):807-10 [PMID: 17676035]
  37. Gastroenterology. 2008 Oct;135(4):1163-7 [PMID: 18727930]
  38. Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1908-18 [PMID: 20647399]
  39. Clin Gastroenterol Hepatol. 2004 Dec;2(12):1088-95 [PMID: 15625654]
  40. World J Gastroenterol. 2008 Jul 7;14(25):3937-47 [PMID: 18609676]
  41. Cell Mol Life Sci. 2006 Sep;63(18):2135-44 [PMID: 16952058]
  42. Gut. 2004 Feb;53(2):261-5 [PMID: 14724161]
  43. Cell. 1991 Aug 9;66(3):589-600 [PMID: 1651174]
  44. Br J Cancer. 2005 Oct 3;93(7):807-10 [PMID: 16175183]
  45. J Ky Med Assoc. 2003 Apr;101(4):142-5 [PMID: 12710248]
  46. World J Gastroenterol. 2009 Apr 14;15(14):1774-8 [PMID: 19360924]
  47. Int J Cancer. 2008 Aug 15;123(4):867-73 [PMID: 18491401]
  48. Indian J Gastroenterol. 2010 Nov;29(6):231-6 [PMID: 21221881]
  49. Lancet. 1997 Jan 4;349(9044):31-2 [PMID: 8988128]
  50. Lancet. 1983 Jan 15;1(8316):111-5 [PMID: 6129425]
  51. Oncogene. 2007 Dec 13;26(57):7825-32 [PMID: 17599048]
  52. Gastroenterology. 2005 Mar;128(3):590-9 [PMID: 15765394]
  53. Cancer Epidemiol Biomarkers Prev. 1998 Mar;7(3):243-51 [PMID: 9521441]
  54. Cancer Lett. 1977 Jul;3(1-2):83-6 [PMID: 890689]
  55. Gastroenterol Clin Biol. 2009 May;33(5):441-5 [PMID: 19278801]
  56. Gut. 2005 May;54(5):617-22 [PMID: 15831904]
  57. Cancer Causes Control. 1993 Mar;4(2):163-9 [PMID: 8481495]
  58. Gut. 2002 May;50(5):647-52 [PMID: 11950810]
  59. Endoscopy. 2009 Jun;41(6):504-9 [PMID: 19533554]
  60. J Int Med Res. 2007 May-Jun;35(3):406-15 [PMID: 17593870]
  61. Gastroenterology. 2008 Jan;134(1):306-23 [PMID: 18166359]
  62. Mol Diagn Ther. 2008;12(5):289-98 [PMID: 18803427]
  63. Dis Colon Rectum. 2002 Jan;45(1):91-7 [PMID: 11786770]
  64. Ann Intern Med. 2003 Apr 1;138(7):560-70 [PMID: 12667026]
  65. Cancer Causes Control. 2004 Feb;15(1):35-43 [PMID: 14970733]
  66. Am Surg. 2007 Nov;73(11):1181-7 [PMID: 18092659]
  67. Cancer. 1990 Aug 15;66(4):702-15 [PMID: 2167140]
  68. Inflamm Bowel Dis. 2004 Jan;10(1):32-5 [PMID: 15058524]
  69. Z Gastroenterol. 1987 Mar;25(3):151-65 [PMID: 3035812]
  70. Cancer. 2001 Feb 15;91(4):854-62 [PMID: 11241255]
  71. Dis Colon Rectum. 2007 Jun;50(6):839-55 [PMID: 17308939]
  72. Ann Surg. 2009 Jan;249(1):63-71 [PMID: 19106677]
  73. Gastroenterology. 2000 Dec;119(6):1447-53 [PMID: 11113065]
  74. Arch Surg. 1990 Aug;125(8):961-5 [PMID: 2378560]
  75. Inflamm Bowel Dis. 2008 Aug;14(8):1154-7 [PMID: 18275076]
  76. Cancer Epidemiol Biomarkers Prev. 1993 Nov-Dec;2(6):551-3 [PMID: 8268772]
  77. J Gastroenterol Hepatol. 2009 Aug;24(8):1347-51 [PMID: 19702902]
  78. Hum Mutat. 2005 Oct;26(4):291-7 [PMID: 16110486]
  79. Cancer Epidemiol Biomarkers Prev. 1997 Sep;6(9):745-8 [PMID: 9298583]
  80. Cancer Causes Control. 2001 Jan;12(1):13-21 [PMID: 11227921]
  81. Arch Surg. 2002 May;137(5):564-70; discussion 570-1 [PMID: 11982470]
  82. Cancer. 1989 Nov 15;64(10):2178-83 [PMID: 2804907]
  83. Gut. 1996 Sep;39(3):439-43 [PMID: 8949651]
  84. Rev Med Interne. 2010 Jun;31(6):428-33 [PMID: 20359791]
  85. Exp Biol Med (Maywood). 2005 Jul;230(7):464-71 [PMID: 15985621]
  86. Cancer Causes Control. 2000 Oct;11(9):791-7 [PMID: 11075867]
  87. BMC Cancer. 2006 Nov 10;6:264 [PMID: 17096841]
  88. Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180 [PMID: 17764220]
  89. BMC Gastroenterol. 2009 Jun 29;9:49 [PMID: 19558729]
  90. Int J Cancer. 1999 Jul 19;82(2):171-4 [PMID: 10389747]
  91. J Occup Health. 2006 Sep;48(5):358-65 [PMID: 17053302]
  92. Int J Cancer. 2008 Sep 15;123(6):1417-21 [PMID: 18561319]
  93. Ann Surg Oncol. 2001 Jul;8(6):496-508 [PMID: 11456049]
  94. Aliment Pharmacol Ther. 2006 May 1;23(9):1297-306 [PMID: 16629934]
  95. Int J Cancer. 1999 Apr 12;81(2):214-8 [PMID: 10188721]
  96. World J Gastroenterol. 2006 Feb 28;12(8):1317-20 [PMID: 16534894]
  97. Clin Cancer Res. 2006 May 15;12(10):3209-15 [PMID: 16707622]
  98. N Engl J Med. 2007 Oct 25;357(17):1731-43 [PMID: 17960014]
  99. J Occup Environ Med. 2002 Jun;44(6):516-22 [PMID: 12085477]
  100. J Natl Cancer Inst. 2007 Nov 7;99(21):1634-43 [PMID: 17971527]
  101. Dig Dis Sci. 2004 Sep;49(9):1479-84 [PMID: 15481323]
  102. Cancer Causes Control. 2002 Feb;13(1):27-34 [PMID: 11899115]
  103. N Engl J Med. 2004 Jan 15;350(3):239-48 [PMID: 14724303]
  104. Dig Dis Sci. 1992 Aug;37(8):1179-84 [PMID: 1499440]
  105. Neth J Med. 1993 Feb;42(1-2):5-11 [PMID: 8446225]
  106. N Engl J Med. 2003 Jun 19;348(25):2517-24 [PMID: 12815137]
  107. JAMA. 2002 Mar 20;287(11):1413-9 [PMID: 11903028]
  108. Aliment Pharmacol Ther. 2006 Apr 15;23(8):1097-104 [PMID: 16611269]
  109. Cancer Chemother Pharmacol. 2011 Jan;67 Suppl 1:S45-50 [PMID: 21140148]
  110. Am J Med. 2003 Aug 15;115(3):191-5 [PMID: 12935825]
  111. Can J Gastroenterol. 1997 Jan-Feb;11(1):65-8 [PMID: 9113802]
  112. Int J Cancer. 1997 Mar 4;70(5):512-7 [PMID: 9052748]
  113. Aliment Pharmacol Ther. 2004 Feb 1;19(3):287-93 [PMID: 14984375]
  114. Scand J Gastroenterol. 2009;44(8):933-8 [PMID: 19492246]
  115. Gastroenterology. 1996 Apr;110(4):1020-7 [PMID: 8612988]
  116. Nihon Rinsho. 2000 Jul;58(7):1400-4 [PMID: 10921312]
  117. Nutr Clin Care. 2005 Apr-Jun;8(2):54-69 [PMID: 16013224]
  118. Gastroenterology. 2002 Nov;123(5):1428-35 [PMID: 12404215]
  119. Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1201-6 [PMID: 8980941]
  120. J Surg Oncol. 2008 Mar 15;97(4):350-9 [PMID: 18286477]
  121. Clin Gastroenterol Hepatol. 2008 Sep;6(9):983-7 [PMID: 18585974]
  122. Postgrad Med J. 1994 Dec;70(830):933-6 [PMID: 7870646]
  123. Cancer Res. 2008 Nov 15;68(22):9274-9 [PMID: 19010900]
  124. J Clin Exp Hematop. 2007 Nov;47(2):31-42 [PMID: 18040143]
  125. Int J Cancer. 2011 May 1;128(9):2202-14 [PMID: 21387287]
  126. Am J Surg Pathol. 2003 May;27(5):625-41 [PMID: 12717247]
  127. Int J Cancer. 1995 Jan 27;60(3):330-3 [PMID: 7829239]
  128. Ann Surg. 1968 Jun;167(6):958-64 [PMID: 17859807]
  129. Gastroenterology. 1993 Dec;105(6):1716-23 [PMID: 8253348]
  130. J Clin Oncol. 2001 Oct 15;19(20):4074-80 [PMID: 11600610]
  131. BMC Gastroenterol. 2006 Dec 04;6:41 [PMID: 17144908]
  132. Int J Oncol. 2008 Dec;33(6):1121-31 [PMID: 19020744]
  133. Am J Surg Pathol. 1989 Dec;13(12):1023-33 [PMID: 2512818]

Word Cloud

Created with Highcharts 10.0.0smallintestinecancercarcinoidtumorsriskfactorsbetterCancer4histologicallymphomasarcomaincidenceincreasedratesetiologydiseaseobesitysmokingsurvivaluncommonmainsubtypes:adenocarcinomaspastseveraldecadesfour-foldincreaselessdramaticrisesadenocarcinomastablelittleknownnotedindividualsCrohn'sceliacadenomafamilialadenomatouspolyposisPeutz-JegherssyndromeSeveralbehavioralincludingconsumptionredsmokedmeatsaturatedfatsuggestedprognosiscarcinomaspoor5yearsrelative<30%lymphomassarcomasbestsignificantchangelong-termsubtypesCurrentlypossibleexceptionscigaretteestablishedmodifiablemightprovidefoundationpreventionprogramaimedreducingmortalitycancersresearchqualitysufficientstatisticalpowerneededgetunderstandingbiologyadditionstudiesdoneassessexposuresinterestalsohostsusceptibilityEpidemiologyHistologyIncidenceRiskSurvival

Similar Articles

Cited By